1965
DOI: 10.1007/bf00402360
|View full text |Cite
|
Sign up to set email alerts
|

Relation between the structure of certain methoxyphenylethylaminederivatives and the occurrence of a Hypokinetic Rigid Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
10
0

Year Published

1970
1970
1978
1978

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(10 citation statements)
references
References 7 publications
0
10
0
Order By: Relevance
“…The compounds tested were apomorphine, which simulates the action of dopamine (see, for example, Ernst, 1965) and methysergide (see, for example, Woodruff, Walker & Kerkut, 1971) and ergometrine (see, for example, Ascher, 1972) which are inhibitors. As Fig.…”
Section: Hyperpolarization Receptorsmentioning
confidence: 99%
“…The compounds tested were apomorphine, which simulates the action of dopamine (see, for example, Ernst, 1965) and methysergide (see, for example, Woodruff, Walker & Kerkut, 1971) and ergometrine (see, for example, Ascher, 1972) which are inhibitors. As Fig.…”
Section: Hyperpolarization Receptorsmentioning
confidence: 99%
“…On the assumption that the present results are relevant to the central nervous system, it is of interest to consider their possible bearing on the theories which attribute certain psychoses to abnormal metabolites (see e.g. Ernst, 1965) which over-stimulate dopaminergic systems (see e.g. Snyder et al, 1974;Matthysse & Lipinski, 1975).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, both DMPEA and its N-acetyl derivative NADMPEA are known to produce behavioural changes in animals, the latter being the more potent (Bindler, Sanghvi & Gershon, 1968;Friedhoff & Schweitzer, 1968). Although these compounds possess the 4-methoxy group necessary for psychotomimetic activity, neither DMPEA nor NADMPEA produce the hallucigenic effects of the structurally similar mescaline when administered orally to man.In addition, reports claiming that DMPEA is present in parkinsonian urine have been supported by Ernst (1965), Barbeau, Tetreault & others (1966) and Shulgin, Sargent & Naranjo (1969) who showed in animal studies, used as a model for parkinsonism, that DMPEA, 3-hydroxy-4-methoxyphenethylamine (3HMPEA) and mescaline produced the characteristic akinesia in rats.A recent report by Barrass, Coult & Pinder (1972) showed that 3HMPEA but not the isomeric 4HMPEA nor DMPEA itself increased dopamine oxidation and inhibited 5-hydroxytryptamine (5-HT) oxidation in vitro. It was suggested, therefore, that 3HMPEA could be the endogenous toxin in parkinsonism producing akinesia and causing an imbalance in the dopamine: 5-HT ratio.…”
mentioning
confidence: 93%
“…Pharmac., 1973, 25,416 Treatment with L-dopa is reported to produce psychotomimetic side-effects (Jenkins & Schweiger, 1971). In schizophrenia, the high dopamine levels in the extrapyramidal system could produce sufficiently high levels of DMPEA for hallucigenic activity and at the same time antagonize the akinetic effects as seen in animal studies (Ernst, 1965). This is supported by the fact that neuroleptic drugs used in the treatment of schizophrenia, effectively reduce dopamine levels by increasing its turnover rate and are well known to produce a parkinsonian syndrome as a side-effect (Ayd, 1961).…”
mentioning
confidence: 95%